Interesting story brought to my attention from reader Troy. It’s from the Dominican newspaper Hoy. And because I forgot all that Spanish I knew 20 years ago, I’m using Google translate to read it.
But the upshot: Bautista spoke at a banquet the other night and noted that in the past two years — the two years which coincided with his tremendous uptick in homers — he has been given sixteen drug tests. In the two years before that he had three total. So I would guess that it’s safe to say that the random drug testing thing has been something less than random in his case.
Now, the real test: given how often Bautista has been tested, if he has 19 homers in late May, can random columnists resist the urge to write that “it’s impossible not to be suspicious” column once again? Or is there nothing that will stop that?
The Blue Jays have signed outfielder Michael Saunders to a minor-league deal, per a club announcement.
Saunders, of course, played for the Blue Jays in 2015 and 2016, putting up a line of .250/.336/.461 in 594 plate appearances. It was his good play in the first half of 2016, in fact, which earned him an All-Star spot and, presumably, made the Phillies think he was worth the $9 million deal they gave him over the offseason. That didn’t work out, as he hit .205/.257/.360 over 61 games and was released last week.
The Phillies will pay the rest of that $9 million. The Jays will see if he has anything in the tank to help them out.
The Giants have placed closer Mark Melancon on the 10-day disabled list with a right pronator strain.
This is the same injury that sent him to the disabled list last month. He came back from that quickly, but it can’t be great that this is happening again. You have to assume he’ll miss more time given the recurrence of trouble. He’s going to get an MRI too. Sam Dyson is expected to serve as the Giants’ closer while Melancon is sidelined.
Melancon has a 4.35 ERA and 11 saves in 22 appearances this year. He signed a four-year, $62 million deal with San Francisco last December.